A Cautionary Consensus on the Use of Ketamine for Depression
The Carlat Psychiatry Report, Volume 15, Number 9&10, September 2017
Taylor Walker Noriega, PharmD candidate (2018)
Ms. Noriega has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Ketamine has become increasingly popular as an off-label medication for rapid onset treatment of refractory depression. Recently, the American Psychiatric Association convened a task force to review the data and come up with some recommendations.